PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11529939-4 2001 We found that Murabutide triggers immunophenotypic changes as upon treatment, iDCs up-regulate the surface expression of the major histocompatibility complex type II molecule human leucocyte antigen-DR, the co-stimulatory molecules CD80, CD86 and CD40 and the differentiation marker CD83, and down-regulate the expression of the mannose receptor. murabutide 14-24 CD83 molecule Homo sapiens 283-287